Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Prosidion Ltd

(OSI) Prosidion is the diabetes and obesity business group within OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) dedicated to the discovery and development of novel drugs for the treatment of type 2 diabetes and obesity. (OSI) Prosidion's lead compound PSN9301 is a Dipeptidyl Peptidase IV (DP-IV) inhibitor currently in Phase II clinical trials. PSN357, a glycogen phosphorylase inhibitor, is undergoing Phase IIa clinical studies and PSN010, a glucokinase activator, has recently entered Phase I clinical trials. (OSI) Prosidion owns or has licensing rights to a portfolio of DP-IV medical use patents with claims covering DP-IV as a target for anti-diabetes therapy and the use of combinations of DP-IV inhibitors with other anti-diabetes drugs such as metformin. A number of non-exclusive licenses to the patent estate have been granted to major pharmaceutical companies. (OSI) Prosidion operates through OSI's wholly-owned subsidiary, Prosidion Limited, in Oxford, UK


Contact Details:
Watlington Road
Oxford
Oxfordshire
OX4 6LT
United Kingdom
Tel:44 (0)1865 782600
Fax:44 (0)1865 782601
Email:Info@Prosidion.com
WWW:

www.prosidion.com/




Loading...

Recent Publications by Prosidion Ltd:

5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
The noradrenaline (NA) and serotonin reuptake inhibitor, sibutramine,...
6th June, 2009
Prosidion Research, Obesity (Silver Spring). 2009 Mar;17(3):467-73. Epub 2008 Dec 11.
DOI Direct Link
SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1.
Allosteric activators of the glucose-sensing enzyme glucokinase (GK) are...
30th August, 2008
OSI) Prosidion, Windrush Court, Watlington Road, Oxford OX4 6LT, United J Med Chem. 2008 Jul 24;51(14):4340-5. Epub 2008 Jun 28.
DOI Direct Link
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity.
GPR119 is a G protein-coupled receptor expressed predominantly in the...
29th April, 2008
(OSI) Prosidion, Br J Pharmacol. 2008 Mar;153 Suppl 1:S76-81. Epub 2007 Nov 26.
DOI Direct Link
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
BACKGROUND AND PURPOSE: Rimonabant (Acomplia, SR141716A), a cannabinoid...
26th February, 2008
Prosidion Limited, Windrush Court, Oxford, UK. Br J Pharmacol. 2007 Nov;152(5):805-14. Epub 2007 Jun 25.
DOI Direct Link
Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions.
AIMS/HYPOTHESIS: We evaluated the insulinotropic and antihyperglycaemic...
18th October, 2007
(OSI)Prosidion, Windrush Court, Watlington Road, Oxford, UK. Diabetologia. 2007 Jun;50(6):1277-87. Epub 2007 Apr 6.
DOI Direct Link

View more Prosidion Ltd research publications.

Press Releases on Prosidion Ltd:

BioPortfolio Logo
Life Sciences Day of DVC Deutsche Venture Capital – Highlights and 1st July, 2004 Dvc
Life Sciences Day of DVC Deutsche Venture Capital – Highlights and Trends in the Biotechno­logy-Sector in Germany 16. July 2004 III. Munich – The third Life Science Day of the DVC has taken
DVC Deutsche Venture Capital achieves a substantial return on the asset 1st January, 1970 Dvc
DVC Deutsche Venture Capital achieves a substantial return on the asset sale of portfolio company Probiodrug to Prosidion Ltd. 9th July 2004 Munich – DVC Deutsche Venture Capital, one of Europe

Prosidion Ltd Patents:

US Patent No.Title
7582632 Tri(cyclo) substituted amide compounds
7262196 Tri(cyclo) substituted amide glucokinase activator compounds
7214681 Tri(cyclo) substituted amide compounds
7166579 Prodrugs of DP IV-inhibitors
7083933 Methods for identification of modulators of OSGPR116 activity

View more Prosidion Ltd patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 6120 times since April 2007, the link to the organisation's website has been followed 1443 times

Recent Search Terms used to find this page: prosidion | prosidion | prosidion | OSI Prosidion | OSI Prosidion | prosidion | prosidion | osi and prosidion | prosidion | prosidion ltd | .

Search for more companies in Oxford

Search for more companies in Oxfordshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Prosidion Ltd

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.